Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€23.97
15.11.21
-
15.11.22
-28.16%
26.11.21

Could be worthwhile Investment >10% per year
buy
Esker S.A.

Start price
Target price
Perf. (%)
€342.00
15.11.21
€340.00
15.11.22
-25.15%
02.02.22

Could be worthwhile Investment >10% per year
Pilbara Minerals Ltd

Start price
Target price
Perf. (%)
€1.57
15.11.21
-
15.11.22
102.23%
15.11.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Bluestone Resources Inc.

Start price
Target price
Perf. (%)
€1.25
15.11.21
-
15.11.22
-15.34%
01.06.22

Could be very worthwhile Investment >20% year
buy
Atari S.A.

Start price
Target price
Perf. (%)
€0.50
15.11.21
€30.00
15.11.22
-72.00%
16.07.22

Could be very worthwhile Investment >20% year
Artprice.com

Start price
Target price
Perf. (%)
€21.65
15.11.21
-
15.11.22
-22.68%
18.11.21

Probably not worthwhile Investment
buy
Secunet Security AG

Start price
Target price
Perf. (%)
€449.50
15.11.21
-
15.11.22
-9.45%
29.11.21

Could be worthwhile Investment >10% per year
Artprice.com

Start price
Target price
Perf. (%)
€19.68
15.11.21
-
15.11.22
-32.83%
26.11.21

Risky Investment
buy
Gaotu Techedu Inc. ADR

Start price
Target price
Perf. (%)
€2.73
15.11.21
-
15.11.22
-8.42%
27.11.21

Risky Investment
buy
Valneva SE

Start price
Target price
Perf. (%)
€21.24
15.11.21
€25.00
15.11.22
33.24%
27.11.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Nel ASA

Start price
Target price
Perf. (%)
€2.04
15.11.21
€1.00
15.11.22
-35.60%
13.11.22

Revenue growth > 30% per year expected
Small challenges to pay loans and raise capital
Future proof or reliable business model
Higher EBIT margin than peer group
Evofem Biosciences Inc.

Start price
Target price
Perf. (%)
€9.04
14.11.21
€4.50
31.12.23
-21.76%
16.11.21

Could be very worthwhile Investment >20% year
buy
Nel ASA

Start price
Target price
Perf. (%)
€2.04
14.11.21
€2.10
14.11.22
-33.78%
15.11.22

Innovative
Future proof or reliable business model
Well known brand
No uniques
Curis Inc.

Start price
Target price
Perf. (%)
€5.06
14.11.21
-
14.11.22
-83.10%
15.11.22

Probably not worthwhile Investment
buy
ALK-Abelló A/S B

Start price
Target price
Perf. (%)
€22.33
13.11.21
€24.00
13.11.22
-37.17%
14.11.22

Future proof or reliable business model
Could be worthwhile Investment >10% per year
buy
Hexo Corp.

Start price
Target price
Perf. (%)
€22.26
13.11.21
€28.00
13.11.22
-88.09%
14.11.22

Higher risks for its business
buy
Callon Petroleum Co.

Start price
Target price
Perf. (%)
€56.00
13.11.21
-
13.11.22
-19.78%
15.09.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Capable Management
Future proof or reliable business model
Catalyst Biosciences Inc

Start price
Target price
Perf. (%)
€0.79
13.11.21
€0.000
13.11.22
-26.11%
27.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Team Inc.

Start price
Target price
Perf. (%)
€13.50
13.11.21
€0.000
13.11.22
-7.41%
27.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
High valuation
EBIT decline/stagnation expected
buy
HOME24 SE

Start price
Target price
Perf. (%)
€12.16
13.11.21
-
13.11.22
-43.22%
13.03.22

buy
Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€7.37
13.11.21
-
13.11.22
-79.10%
14.11.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Innovative
Top 10 in its market
buy
Apellis Pharmaceuticals

Start price
Target price
Perf. (%)
€37.80
13.11.21
€50.00
31.12.23
11.71%
29.06.22

Could be very worthwhile Investment >20% year
buy
Argan

Start price
Target price
Perf. (%)
€112.20
12.11.21
€118.00
12.11.22
-27.90%
13.11.22

Could be worthwhile Investment >10% per year
Altamira Therapeutics Ltd.

Start price
Target price
Perf. (%)
€2.40
12.11.21
-
12.11.22
-20.42%
14.11.21

Risky Investment
buy
Catalyst Biosciences Inc

Start price
Target price
Perf. (%)
€0.89
12.11.21
-
12.11.22
-14.69%
15.11.21

Risky Investment